ZBTB7A and leukemia: ,21,22 By targeting the HBG1/2 promoters, we have shown that it is possible to evict the leukemia/lymphoma-related factor (LRF; also known as ZBTB7A or FBI-1), a known repressor of HBG expression and reactivate HbF.22